St. John's Institute of Dermatology
London, United Kingdom
Research institute in London, England
The Nightingale School, 2 Lambeth Palace Rd, London SE1 7EP
About St. John's Institute of Dermatology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eisai Inc.
2
Biogen
1
Seagen Inc.
1
University of Nottingham
1
Clinical Trials at St. John's Institute of Dermatology
During the past decade, St. John's Institute of Dermatology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients
1995-06-01
2006-12-01
Completed
195
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
1995-09-01
2006-12-01
Completed
86
Safety and Tolerability of Repeat Courses of IM Alefacept
2002-12-01
2005-06-01
Completed
400
A Treatment-Option Protocol to Provide Brentuximab Vedotin to Eligible Patients Completing Studies SGN35-005 or C25001
No longer available
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "St. John's Institute of Dermatology"
#1 collaborator was "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "National Institute for Health Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at St. John's Institute of Dermatology
According to Clinical.Site data, the most researched conditions in "St. John's Institute of Dermatology" are
"Lymphoma, T-Cell, Cutaneous" (3 trials), "Mycosis Fungoides" (2 trials), "Sezary Syndrome" (2 trials), "Chronic Plaque Psoriasis" (1 trials) and "Disease, Hodgkin" (1 trials). Many other conditions were trialed in "St. John's Institute of Dermatology" in a lesser frequency.
Clinical Trials Intervention Types at St. John's Institute of Dermatology
Most popular intervention types in "St. John's Institute of Dermatology" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "ONTAK" (2 trials), "Alefacept" (1 trials), "Best practice skin care advice booklet" (1 trials), "Experimental (Doublebase Gel® or Diprobase Cream®)" (1 trials) and "brentuximab vedotin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St. John's Institute of Dermatology
The vast majority of trials in "St. John's Institute of Dermatology" are
5 trials for "All" genders.
Clinical Trials Status at St. John's Institute of Dermatology
Currently, there are NaN active trials in "St. John's Institute of Dermatology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in St. John's Institute of Dermatology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. John's Institute of Dermatology, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".